We're an early stage (3 FTEs) biotech company revolutionizing drug discovery with our technology capable of quantitatively characterizing proteins (antibodies) with 1000x more throughput than competing technologies. We just raised an $18M Series A led by ARCH Venture Partners and Illumina Ventures and looking to hire!
Please see our website for openings - https://www.protillion.com/